SERI® Surgical Scaffold + Tissue1
SERI® Surgical Scaffold, along with newly ingrown tissue, was shown to exhibit neovascularization.1
Sericin is extracted from the fiber, leaving behind fibroin protein with minimal residual sericin1,4
The purified bioengineering process removes the sercin, leaving behind fibroin protein filament of ≥ 95% purity on average.1,3,4
Methodology: In a study using SERI® Surgical Scaffold in a rat model of abdominal wall defect, SERI® Surgical Scaffold plus tissue sample was taken after 4 weeks following implantation. In a separate rat model study, scar tissue sample was taken after 7 weeks following implantation and identified from the incision site.1
Note: Similar studies in humans have not been performed.
Support and Strength From Native Tissue1,*